These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 31680940)

  • 1. Pharmacokinetics and Pharmacodynamics of Gamithromycin Treatment of
    Yang Q; Liu X; Zhang C; Yong K; Clifton AC; Ding H; Liu Y
    Front Pharmacol; 2019; 10():1090. PubMed ID: 31680940
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Pharmacokinetics and Pharmacodynamics of Tildipirosin Against
    Zeng D; Sun M; Lin Z; Li M; Gehring R; Zeng Z
    Front Microbiol; 2018; 9():1038. PubMed ID: 29867911
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Pharmacokinetics and pharmacodynamics of gamithromycin in pulmonary epithelial lining fluid in naturally occurring bovine respiratory disease in multisource commingled feedlot cattle.
    DeDonder KD; Apley MD; Li M; Gehring R; Harhay DM; Lubbers BV; White BJ; Capik SF; KuKanich B; Riviere JE; Tessman RK
    J Vet Pharmacol Ther; 2016 Apr; 39(2):157-66. PubMed ID: 26441021
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Pharmacokinetic/pharmacodynamic evaluation of gamithromycin against rabbit pasteurellosis.
    Wei XY; Zhang J; Zhang Y; Fu WZ; Zhong LG; Pan YD; Sun J; Liao XP; Liu YH; Zhou YF
    BMC Vet Res; 2024 Apr; 20(1):147. PubMed ID: 38643185
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increased Antimicrobial Activity of Colistin in Combination With Gamithromycin Against
    Li Y; Xie M; Zhou J; Lin H; Xiao T; Wu L; Ding H; Fang B
    Front Microbiol; 2020; 11():511356. PubMed ID: 33072002
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Pharmacokinetic/pharmacodynamic integration and modelling of amoxicillin for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Pelligand L; Illambas J; Potter T; Lacroix M; Rycroft A; Toutain PL
    J Vet Pharmacol Ther; 2015 Oct; 38(5):457-70. PubMed ID: 25669418
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Pharmacokinetic-pharmacodynamic integration and modelling of florfenicol in calves.
    Sidhu P; Rassouli A; Illambas J; Potter T; Pelligand L; Rycroft A; Lees P
    J Vet Pharmacol Ther; 2014 Jun; 37(3):231-42. PubMed ID: 24341543
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacokinetic-pharmacodynamic integration and modelling of oxytetracycline for the calf pathogens Mannheimia haemolytica and Pasteurella multocida.
    Lees P; Potter T; Pelligand L; Toutain PL
    J Vet Pharmacol Ther; 2018 Feb; 41(1):28-38. PubMed ID: 28736817
    [TBL] [Abstract][Full Text] [Related]  

  • 9.
    Xiao X; Lan W; Zhao Y; Li R; Liu Y; Liu J; Wang Z
    Front Microbiol; 2020; 11():616685. PubMed ID: 33505384
    [No Abstract]   [Full Text] [Related]  

  • 10. Optimizing tylosin dosage for co-infection of
    Lee EB; Abbas MA; Park J; Tassew DD; Park SC
    Front Pharmacol; 2023; 14():1258403. PubMed ID: 37808183
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pharmacokinetics/pharmacodynamics of marbofloxacin in a Pasteurella multocida serious murine lung infection model.
    Qu Y; Qiu Z; Cao C; Lu Y; Sun M; Liang C; Zeng Z
    BMC Vet Res; 2015 Dec; 11():294. PubMed ID: 26631082
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epidemiological and PK/PD cutoff values determination and PK/PD-based dose assessment of gamithromycin against Haemophilus parasuis in piglets.
    Zhou YF; Bu MX; Liu P; Sun J; Liu YH; Liao XP
    BMC Vet Res; 2020 Mar; 16(1):81. PubMed ID: 32138735
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Pharmacokinetics and pharmacodynamics of enrofloxacin treatment of Escherichia coli in a murine thigh infection modeling.
    Liu X; Yang Q; Fan Y; Du Y; Lei L; Wang D; Liu Y
    BMC Vet Res; 2021 Jun; 17(1):212. PubMed ID: 34107961
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Pharmacokinetic/Pharmacodynamic Modeling of Tulathromycin against
    Zhou Q; Zhang G; Wang Q; Liu W; Huang Y; Yu P; Li Y; Ding H; Fang B
    Front Pharmacol; 2017; 8():392. PubMed ID: 28701951
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Pharmacokinetic and pharmacodynamic integration and modelling of marbofloxacin in calves for Mannheimia haemolytica and Pasteurella multocida.
    Potter T; Illambas J; Pelligand L; Rycroft A; Lees P
    Vet J; 2013 Jan; 195(1):53-8. PubMed ID: 23084327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pharmacokinetic-pharmacodynamic relationship of marbofloxacin for Escherichia coli and Pasturella multocida following repeated intramuscular administration in goats.
    Bhardwaj P; Sidhu PK; Saini SPS; M B D; Rampal S
    J Vet Pharmacol Ther; 2019 Jul; 42(4):430-439. PubMed ID: 31102281
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Integrated pharmacokinetic-Pharmacodynamic (PK/PD) model to evaluate the in vivo antimicrobial activity of Marbofloxacin against Pasteurella multocida in piglets.
    Zeng QL; Mei X; Su J; Li XH; Xiong WG; Lu Y; Zeng ZL
    BMC Vet Res; 2017 Jun; 13(1):178. PubMed ID: 28619095
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Optimization and Validation of Dosage Regimen for Ceftiofur against
    Mi K; Pu S; Hou Y; Sun L; Zhou K; Ma W; Xu X; Huo M; Liu Z; Xie C; Qu W; Huang L
    Int J Mol Sci; 2022 Mar; 23(7):. PubMed ID: 35409082
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pharmacodynamic Target Assessment and PK/PD Cutoff Determination for Gamithromycin Against
    Wang RL; Liu P; Chen XF; Yao X; Liao XP; Liu YH; Sun J; Zhou YF
    Front Vet Sci; 2022; 9():945632. PubMed ID: 35898553
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacodynamics of marbofloxacin for calf pneumonia pathogens.
    Illambas J; Potter T; Cheng Z; Rycroft A; Fishwick J; Lees P
    Res Vet Sci; 2013 Jun; 94(3):675-81. PubMed ID: 23375665
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.